Definitely yes to 2mg x 2 week dose given reduced dose request was based on an anomaly from historic study on a rat BUT no to removing adrenal monitoring despite follow-up studies that confirmed it wasn't linked to PPS.
FDA burnt too many times and given OA TAM potential they want to show extreme prudence.
Not a major deal rather impacts on patient convenience (takes extra time), their comfort and our cost.
2x2 Yay Or Nay From The FDA?, page-8
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.005(1.96%) |
Mkt cap ! $90.94M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 26.5¢ | 25.5¢ | $68.76K | 262.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 230258 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 70769 | 7 |
View Market Depth
| Last trade - 14.27pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.0¢ |
Change
0.005 ( 0.58 %) |
||||
| Open | High | Low | Volume | ||
| 26.0¢ | 26.5¢ | 26.0¢ | 91886 | ||
| Last updated 14.29pm 27/05/2024 ? | |||||
| PAR (ASX) Chart |